Efficacy and Safety of Pegylated Interferon Alfa-2b and Ribavirin Combination Therapy Versus Pegylated Interferon Monotherapy in Hemodialysis Patients: A Comparison of 2 Sequentially Treated Cohorts

W1016 Efficacy and Safety of Erythropoietin-Alfa On NaïVe Patients with Chronic Hepatitis C and Genotype 1 Receiving Combination Therapy with Pegylated Interferon-Alfa 2b and Ribavirin

Gastroenterology ◽

10.1016/s0016-5085(08)63892-5 ◽

2008 ◽

Vol 134 (4) ◽

pp. A-832-A-833

Author(s):

Dagmary Purcell ◽

Doris H. Toro

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Efficacy And Safety ◽

Genotype 1 ◽

Erythropoietin Alfa

Pegylated interferon alfa-2b plus ribavirin in patients with chronic hepatitis C: A trial in prior nonresponders to interferon monotherapy or combination therapy and in combination therapy relapsers: Final results

Gastroenterology ◽

10.1016/s0016-5085(03)83604-1 ◽

2003 ◽

Vol 124 (4) ◽

pp. A714 ◽

Cited By ~ 9

Author(s):

Ira M. Jacobson ◽

Furqaan Ahmed ◽

Mark W. Russo ◽

Robert S. Brown ◽

Edward Lebovics ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Interferon Monotherapy ◽

Prediction of Sustained Virological Response to Combination Therapy with Pegylated Interferon Alfa and Ribavirin in Patients with Genotype 3 Chronic Hepatitis C

Digestive Diseases and Sciences ◽

10.1007/s10620-011-1770-3 ◽

2011 ◽

Vol 56 (8) ◽

pp. 2449-2455 ◽

Cited By ~ 25

Author(s):

S. K. Tohra ◽

S. Taneja ◽

S. Ghosh ◽

B. K. Sharma ◽

A. Duseja ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Sustained Virological Response ◽

Chronic Hepatitis C ◽

Virological Response ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Genotype 3 ◽

[572] RANDOMIZED, OPEN LABEL TRIAL COMPARING EFFICACY AND SAFETY OF PEGYLATED INTERFERON ALFA 2b VS ALFA 2b TREATMENT OF PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH NON 2/3 GENOTYPES - FINAL ANALYSIS

Journal of Hepatology ◽

10.1016/s0168-8278(07)62170-9 ◽

2007 ◽

Vol 46 ◽

pp. S217-S218 ◽

Cited By ~ 1

Author(s):

H. Berak ◽

A. Kolakowska-Rzadzka ◽

M. Wasilewski ◽

J. Kowalska ◽

J.J. Stanczak ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Final Analysis ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Trial

Efficacy and safety of daclatasvir plus pegylated-interferon alfa 2a and ribavirin in previously untreated HCV subjects coinfected with HIV and HCV genotype-1: a Phase III, open-label study

Hepatology International ◽

10.1007/s12072-017-9788-z ◽

2017 ◽

Vol 11 (2) ◽

pp. 188-198 ◽

Cited By ~ 2

Author(s):

Mark S. Sulkowski ◽

Walford J. Fessel ◽

Adriano Lazzarin ◽

Juan Berenguer ◽

Natalia Zakharova ◽

...

Keyword(s):

Pegylated Interferon ◽

Interferon Alfa ◽

Phase Iii ◽

Efficacy And Safety ◽

Genotype 1 ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Hcv Genotype 1

Pegylated Interferon Alfa‐2a Monotherapy for Hemodialysis Patients with Acute Hepatitis C

Clinical Infectious Diseases ◽

10.1086/655682 ◽

2010 ◽

Vol 51 (5) ◽

pp. 541-549 ◽

Cited By ~ 23

Author(s):

Chen‐Hua Liu ◽

Cheng‐Chao Liang ◽

Chun‐Jen Liu ◽

Jou‐Wei Lin ◽

Shih‐I Chen ◽

...

Keyword(s):

Hepatitis C ◽

Acute Hepatitis ◽

Pegylated Interferon ◽

Hemodialysis Patients ◽

Interferon Alfa ◽

Acute Hepatitis C ◽

[626] PRE-DOSING TARIBAVIRIN PRIOR TO COMBINATION THERAPY WITH PEGYLATED INTERFERON ALFA-2b VERSUS STANDARD COMBINATION DOSING: 24-WEEK INTERIM RESULTS EXAMINING SAFETY AND VIRAL KINETICS

Journal of Hepatology ◽

10.1016/s0168-8278(07)62224-7 ◽

2007 ◽

Vol 46 ◽

pp. S236-S237 ◽

Cited By ~ 1

Author(s):

M. Palmer ◽

R. Rubin ◽

V. Rustgi ◽

D. Li ◽

B. Murphy

Keyword(s):

Combination Therapy ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Viral Kinetics ◽

Pegylated interferon alfa-2a (PEGASYSTM) and ribavirin combination therapy for chronic hepatitis C: A phase II open-label study

Gastroenterology ◽

10.1016/s0016-5085(00)85944-2 ◽

2000 ◽

Vol 118 (4) ◽

pp. A950 ◽

Cited By ~ 11

Author(s):

Mark S. Sulkowski ◽

Robert Reindollar ◽

J. Yu

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Combination Therapy ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

HBsAg seroconversion in a HIV co-infected patient during combination therapy with adefovir dipivoxil and pegylated interferon alfa 2b followed by HBsAg seroreversion and viral reoccurrence after stopping HBV directed antiviral treatment

Zeitschrift für Gastroenterologie ◽

10.1055/s-2006-951251 ◽

2006 ◽

Vol 44 (08) ◽

Author(s):

K Wursthorn ◽

P Buggisch ◽

M Lütgehetmann ◽

B Zöllner ◽

J Petersen

Keyword(s):

Combination Therapy ◽

Infected Patient ◽

Adefovir Dipivoxil ◽

Antiviral Treatment ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Hbsag Seroconversion

319 Treatment with pegylated-interferon alfa 2B in relapsers to standard interferon + ribavirin in chronic hepatitis C: Efficacy and safety results from a randomized multicentric French study

Hepatology ◽

10.1016/s0270-9139(03)80362-2 ◽

2003 ◽

Vol 38 ◽

pp. 311-311 ◽

Cited By ~ 2

Author(s):

I PORTAL ◽

D BOTTAFRIDLUND ◽

M BOULIERE ◽

M ROTILY ◽

P HALFON ◽

...

Keyword(s):

Chronic Hepatitis ◽

Hepatitis C ◽

Chronic Hepatitis C ◽

Pegylated Interferon ◽

Interferon Alfa ◽

Efficacy And Safety ◽

Standard Interferon ◽

French Study ◽